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Abstract: The responsiveness of central noradrenergic systems to stressors
and cocaine poses norepinephrine as a potential common mechanism through
which drug re-exposure and stressful stimuli promote relapse. This study
investigated the role of noradrenergic systems in the reinstatement of
extinguished cocaine-induced conditioned place preference by cocaine and
stress in male C57BL/6 mice. Cocaine- (15 mg/kg, i.p.) induced conditioned
place preference was extinguished by repeated exposure to the apparatus in
the absence of drug and reestablished by a cocaine challenge (15 mg/kg),
exposure to a stressor (6-min forced swim (FS); 20–25°C water), or
administration of the -2 adrenergic receptor (AR) antagonists yohimbine
(2 mg/kg, i.p.) or BRL44408 (5, 10 mg/kg, i.p.). To investigate the role of
ARs, mice were administered the nonselective β-AR antagonist, propranolol
(5, 10 mg/kg, i.p.), the -1 AR antagonist, prazosin (1, 2 mg/kg, i.p.), or the

-2 AR agonist, clonidine (0.03, 0.3 mg/kg, i.p.) before reinstatement testing.
Clonidine, prazosin, and propranolol failed to block cocaine-induced
reinstatement. The low (0.03 mg/kg) but not high (0.3 mg/kg) clonidine dose
fully blocked FS-induced reinstatement but not reinstatement by yohimbine.
Propranolol, but not prazosin, blocked reinstatement by both yohimbine and
FS, suggesting the involvement of β-ARs. The β-2 AR antagonist ICI-118551
(1 mg/kg, i.p.), but not the β-1 AR antagonist betaxolol (10 mg/kg, i.p.), also
blocked FS-induced reinstatement. These findings suggest that stress-induced
reinstatement requires noradrenergic signaling through β-2 ARs and that
cocaine-induced reinstatement does not require AR activation, even though
stimulation of central noradrenergic neurotransmission is sufficient to
reinstate.
Keywords: relapse, norepinephrine, propranolol, prazosin, clonidine, beta
adrenergic receptors
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Introduction
The sudden reemergence of cocaine craving even after
protracted periods of abstinence and the resulting relapse of drug use
represent formidable obstacles to the effective management of cocaine
addiction. Anecdotal reports and clinical and preclinical research have
identified stress and cocaine re-exposure as likely precipitating events
for drug relapse (Shaham et al, 2000a, 2000b, 2003; Sinha, 2001;
Stewart, 2003; Lu et al, 2003). Understanding the neurobiological
mechanisms that contribute to the relapse of drug use in response to
these stimuli should lead to the development of new and more
effective approaches for treating addiction.
The preclinical study of relapse involves the use of
reinstatement protocols in which the ability of various stimuli to
reestablish extinguished drug-seeking behavior is examined (Shaham
et al, 2003). For example, in rats and monkeys, cocaine administration
or exposure to a variety of stressors will reinstate extinguished lever
pressing that was previously reinforced by cocaine delivery (see
Shaham et al, 2000a, 2000b, 2003; Sinha, 2001; Stewart, 2003; Lu et
al, 2003 for reviews). Relapse can also be investigated using a
conditioned place preference reinstatement approach in which the
ability of stimuli to reestablish extinguished preference for a previously
cocaine-paired environment is examined (Tzschentke, 2007). In mice,
extinguished cocaine-induced conditioned place preference can be
reinstated by administration of a priming injection of cocaine (Itzhak
and Martin, 2002; Orsini et al, 2008) or by exposure to stressors,
including social stress (Ribeiro Do Couto et al, 2006), uncontrollable
electric footshock (Redila and Chavkin, 2008), or forced swim (Kreibich
and Blendy, 2004). The use of mouse reinstatement models is
important in that it should facilitate the application of genetic
approaches not available in other species to further advance
understanding of relapse substrates.
The responsiveness of central noradrenergic systems to both
stressors (Abercrombie et al, 1988; Tanaka et al, 1991; Finlay et al,
1995) and cocaine (Reith et al, 1997; Li et al, 1996) poses
norepinephrine (NE) as a potential common mechanism through which
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drug re-exposure and stressful environmental stimuli promote relapse.
Accordingly, previous studies have suggested that antagonizing
adrenergic receptors (ARs; Leri et al, 2002; Zhang and Kosten, 2005)
or suppressing noradrenergic neurotransmission (Erb et al, 2000; Platt
et al, 2007) can attenuate cocaine seeking, whereas augmenting
adrenergic neurotransmission through antagonism of -2 adrenergic
autoreceptors (Lee et al, 2004; Feltenstein and See, 2006; Fletcher et
al, 2008; Brown et al, 2009) or blockade of reuptake (Platt et al,
2007; but see Schmidt and Pierce, 2006) can evoke cocaine seeking
as measured using reinstatement protocols. Considering that in human
cocaine addicts, drug craving is associated with a robust peripheral
adrenergic response (Sinha et al, 2003) that seems to be augmented
during early withdrawal (McDougle et al, 1994) and that repeated
cocaine exposure produces long-lasting adaptations within central
noradrenergic systems that may lead to enhanced noradrenergic
responsiveness during stress (Belej et al, 1996; Macey et al, 2003;
Baumann et al, 2004; Beveridge et al, 2005; Lanteri et al, 2008),
central noradrenergic signaling may represent an important
therapeutic target for the prevention of relapse (Weinshenker and
Schroeder, 2007; Smith and Aston-Jones, 2008; Sofuoglu and Sewell,
2009).
This study investigated the role of noradrenergic systems in the
reinstatement of extinguished cocaine-induced conditioned place
preference by cocaine and stress in adult male C57 BL/6 mice. The
effects of the -1 AR antagonist, prazosin, the β-AR antagonists,
propranolol, betaxolol, and ICI-118551, and the -2 AR agonist,
clonidine, on reinstatement by cocaine, forced swim (FS) stress,
and/or the -2 AR antagonist, yohimbine, were examined. Our findings
suggest that noradrenergic activation of β-2 ARs is selectively involved
in stress-induced reinstatement.

Materials and Methods
Subjects
A total of 250 male C57BL/6 mice (8–9 weeks old) were used
(Harlan). Mice were housed singly in a temperature- and humidityNeuropsychopharmacology, Vol. 35, No. 11 (October 2010): pg. 2165-78. DOI. This article is © Nature Publishing Group
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controlled, AAALAC-accredited animal facility under a 12/12 h
light/dark cycle (lights on at 0700 hours) and had access to food and
water at all times, except when in the experimental chambers. All
procedures were carried out in accordance with the Guide for the Care
and Use of Laboratory Animals as adopted and promulgated by the
NIH.

Drugs
Cocaine HCl was acquired from the National Institute on Drug
Abuse (NIDA) through the NIDA Drug Supply Program. Clonidine HCl,
±propranolol HCl, betaxolol HCl, ICI-118551 HCl, and yohimbine HCl
were purchased from Sigma-Aldrich. BRL 44408 maleate was acquired
from Tocris Bioscience. Yohimbine, prazosin, and clonidine were
dissolved in sterile water. Cocaine, propranolol, betaxolol, ICI-118551,
and BRL 44408 were dissolved in saline (0.9% NaCl solution). All drug
solutions were administered i.p. in a volume of 0.1 ml per 20 g body
mass.

Equipment
Behavioral testing was conducted using four ENV-3013 mouse
place preference chambers from Med-Associates, Inc. The stainless
steel and polyvinyl chloride chambers consisted of three distinct
compartments separated by 5 cm wide × 5.9 cm high manual guillotine
doors. The two 46.5 × 12.7 × 12.7 cm3 side compartments consisted
of a white compartment with a 6.35 × 6.35 mm2 stainless steel mesh
floor and a black compartment with a stainless steel grid rod floor
consisting of 3.2 mm rods spaced 7.9 mm apart. The side
compartments were attached by a gray-colored 7.2-cm-long center
compartment with a smooth floor. The clear tops of the compartments
were hinged to permit placement and removal of the mice. Ceiling
lights were attached to each top. To balance unconditioned side
preference, only the light in the black compartment was illuminated
during training or testing. Automated data collection was accomplished
using photobeams (six beams for the white and black test areas and
two beams for the center gray area), which were evenly spaced across
the length of the chamber and interfaced with a computer containing
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Med-PC software. Using this automated photobeam system, entry into
a side compartment was defined as consecutive breaks of the first two
photocell beams in that compartment located adjacent to the door
separating that compartment from the center compartment. Exiting of
a side compartment (and entry into the center compartment) was
indicated by occlusion of the beams in the center compartment.

Cocaine-Induced Conditioned Place Preference
Cocaine-induced conditioned place preference was established
using a design in which one of the side compartments was randomly
designated as the cocaine compartment and the other as the saline
compartment. On the first day of the procedure, mice were placed into
the center compartment of the chamber and provided free access to
both side compartments for 30 min in the absence of saline or cocaine
pretreatment to determine preconditioning preference. During the 8day conditioning phase of the experiment, mice received cocaine
(15 mg/kg, i.p.) and saline injections on alternating days, after which
they were confined to the randomly designated treatment-appropriate
compartment for 30 min. After the final conditioning session, mice
were tested for the expression of cocaine-induced conditioned place
preference by once again placing them into the center compartment of
the chamber and providing them with free access to the side
compartments for 30 min. Conditioned place preference was defined as
the change in time spent (seconds) within the cocaine-paired
compartment after conditioning when compared with the initial
preconditioning session. The 15 mg/kg cocaine dose was selected on
the basis of results of a preliminary study in which the ability of
various cocaine doses to produce place preference was examined
(Figure 1a).
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Figure 1

Induction and reinstatement of cocaine-induced conditioned place

preference. Cocaine dose-dependently induced conditioned place preference with peak
effects at the 15 mg/kg (i.p.) dose. Data in (a) represent the mean change in time
spent (sec±SE) in the cocaine-paired compartment between the pre- and postconditioning test sessions in mice that were conditioned with various cocaine doses
(0–30 mg/kg, i.p.; n=10–20/group). On the basis of these data, the 15 mg/kg cocaine
dose was selected as the conditioning and reinstatement dose for each experiment. (b
and c) Show the reinstatement of extinguished cocaine-induced conditioned place
preference by cocaine (Coc; 10 mg/kg, i.p.; n=23; b), physical restraint (Res; n=26;
b), forced swim (FS; n=16; b), and by the -2 AR antagonists yohimbine (Yoh; 1 and
2 mg/kg, i.p.; n=23; c) and BRL 44408 (BRL; 2.5, 5, and 10 mg/kg, i.p.; n=6–8; c).
Data represent the time spent in the Coc compartment (sec±SE) during the 30-min
reinstatement (Rst) session (filled bars) or during the preceding extinction session
(open bars). Coc, FS, 2 mg/kg Yoh, and 5 and 10 mg/kg BRL but not Res, 1 mg/kg Yoh
or 2.5 mg/kg BRL, produced significant reinstatement (*p<0.05 vs Ext).

Extinction
After conditioning, daily extinction training was conducted.
During the extinction sessions, mice were placed into the center
compartment and once again provided free access to the side
compartments for 30 min. Mice underwent daily extinction training
until the preference for the cocaine-paired compartment during the
session (ie, change in time spent in the cocaine side relative to
preconditioning values) was reduced by at least 50% compared with
the post-conditioning test session, at which time reinstatement testing
was conducted.

Reinstatement Testing
The reinstatement sessions were identical to the extinction
sessions, except that mice received exposure to stressors and/or drug
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injections before the session. Reinstatement was defined according to
the time spent in the compartment previously paired with cocaine.
Mice were tested more than once for reinstatement. Generally, each
mouse was tested with each of the three reinstating stimuli (cocaine,
forced swim (FS), and yohimbine) alone and in combination with one
drug pretreatment and its respective vehicle in counter-balanced order
to avoid potential sequence effects. Reinstatement sessions were
separated by additional extinction sessions. Mice were required to
reach the extinction criterion once again before the next reinstatement
test was conducted. Initially, separate groups of mice were tested for
the ability of various stressors and drugs, when delivered in the
absence of pretreatments, to produce reinstatement.

Drug-Induced Reinstatement
Cocaine- and yohimbine-induced reinstatement testing was
conducted by injecting mice with cocaine (15 mg/kg, i.p.) or yohimbine
(1 or 2 mg/kg, i.p.) either alone or 30 min after pretreatment with
clonidine (0.03 and 0.3 mg/kg), propranolol (5 and 10 mg/kg),
prazosin (1 and 2 mg/kg), betaxolol (10 mg/kg), or ICI-118551
(10 mg/kg), or their respective vehicles and placing mice into the
center compartment 5 min later with free access to both sides of the
compartment for 30 min. Reinstatement by clonidine, propranolol,
prazosin, betaxolol, and ICI-118551 alone was also tested after
administration 30 min before the reinstatement session, a time point
that matched the pretreatment time when these drugs were
administered before cocaine, yohimbine, or FS during testing. To
confirm that antagonism of -2 AR by yohimbine may have contributed
to reinstatement, a separate group of mice was tested for
reinstatement in response to the highly selective -2 AR antagonist,
BRL 44408 (2.5, 5, and 10 mg/kg, i.p.).

Stress-Induced Reinstatement
FS-induced reinstatement was examined by placing mice into a
30 cm high × 20 cm deep cylindrical polypropylene container filled with
water (20–25°C) for 6 min, 30 min after pretreatment with clonidine
(0.03 and 0.3 mg/kg), propranolol (5 and 10 mg/kg), prazosin (1 and
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2 mg/kg), or their respective vehicles. After FS, mice were placed back
into their home cages for 3–4 min before introducing them into the
center compartment of the place conditioning chamber with free
access to both of the side compartments for reinstatement testing, as
described above. Initially, some mice were also tested for
reinstatement following 5 min of physical restraint using a mouse
restrainer cone (5.7 cm diameter tapered to 1.2 cm diameter; 11 cm
length). These mice were also returned to their home cages after
restraint for 3–4 min before placement into the apparatus for
reinstatement testing. As propranolol blocked FS-induced
reinstatement, we also tested the mice for the effects of the selective
β-1 AR antagonist, betaxolol (10 mg/kg, i.p.), and the selective β-2 AR
antagonist, ICI-118551 (1 mg/kg, i.p.), on reinstatement after FS.

Locomotor Testing
To assist with dose selection, the effects of various doses of
clonidine, prazosin, and propranolol on locomotor activity were tested
in 26 mice using an automated AccuScan activity system (AccuScan
Instruments, Inc., Columbus, OH) consisting of a frame containing
photocells (eight per cage), in which clear Plexiglas 29.5 cm long ×
19 cm wide × 12.7 cm high cages were placed. Activity was measured
as total photobeam breaks. During the week before the locomotor
testing, mice were habituated to the test environment during two 2-h
sessions. On the test day, mice were placed into the chambers for 2 h
before the drug administration, after which was measured over a 2-h
period. The effects of clonidine (0, 0.03, 0.3, and 1 mg/kg, i.p.),
prazosin (0, 1, 2, and 4 mg/kg, i.p.), and propranolol (0, 5, 10, and
20 mg/kg, i.p.) were tested in separate groups of mice. Only doses
that failed to produce statistically significant reductions in activity were
tested for effects on reinstatement.

Statistical Analyses
Place preference during testing, extinction, and reinstatement
was defined as the time spent (sec) in the designated cocaine
compartment. The abilities of individual stimuli to reinstate place
preference in the absence of drug pretreatments were examined
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statistically using two-tailed Student's t-tests comparing the time
spent in the cocaine compartment during the previous extinction
session with that during the reinstatement session. The significance of
the effects of drug pretreatments on reinstatement by each of the
stimuli was determined using two-way repeated measures
reinstatement × drug pretreatment ANOVA followed by post-hoc
testing using two-tailed Student's t-tests. The significance of doserelated drug effects on locomotor activity was determined using oneway (drug dose) ANOVA followed by post-hoc testing using the
Dunnett's test. For all analyses, significance was defined as p<0.05.

RESULTS
Establishment and Reinstatement of Cocaine-Induced
Conditioned Place Preference
Dose–response analysis showed that the 15 mg/kg cocaine dose
was optimal for producing conditioned place preference (n=10–20
mice per cocaine/veh dose; Figure 1a). Although not shown, significant
cocaine-induced conditioned place preference, defined as an increase
in time spent in the cocaine-paired compartment, was observed in
each of the experiments in which reinstatement was later examined
(p<0.05 for each experiment). The overall average number of
extinction sessions before the first reinstatement test session was
8.757. Overall, 28 mice (out of 224 that underwent conditioning) were
not tested for reinstatement, because they either did not show
cocaine-induced conditioned place preference or failed to reach the
extinction criterion.
The ability of cocaine and stress to reinstate extinguished
cocaine-induced place preference is shown in Figure 1b. Administration
of 15 mg/kg cocaine (t22=4.949; n=23) or FS (t15=3.128; n=16), but
not restraint (n=26), significantly increased the time spent in the
cocaine compartment following extinction (p<0.01).
To determine whether stimulating central noradrenergic
neurotransmission through antagonism of -2 AR is sufficient to induce
reinstatement, mice were tested for the ability of yohimbine and the
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more selective -2A AR antagonist, BRL 44408, to reinstate
extinguished place preference (Figure 1c). For yohimbine, a two-way
reinstatement condition (repeated measure) × yohimbine dose (1 vs
2 mg/kg) ANOVA showed a significant overall effect of reinstatement
condition (F1,33=5.252; p<0.05) but not yohimbine dose, and a
significant reinstatement condition × dose interaction (F1,33=4.089;
p=0.05). The 2 mg/kg (t22=3.371; n=23), but not 1 mg/kg (n=23),
yohimbine dose produced significant reinstatement (p<0.01). Although
yohimbine can increase central noradrenergic neurotransmission
through antagonism of -2 ARs, it also binds to several other
receptors, including the 5-HT1A receptor, where it functions as an
antagonist and may produce effects independently of the
noradrenergic system (Sanger and Schoemaker, 1992; Winter and
Rabin, 1992). To confirm that -2 AR antagonism is sufficient to
induce reinstatement, we also tested some mice for reinstatement
after administration of the selective -2A AR antagonist BRL 44408,
which has a 50-fold higher affinity for -2A AR relative to 5-HT1A
receptors (Dwyer et al, 2010). A two-way repeated-measures
reinstatement condition × BRL 44408 dose (2.5, 5.0, 10.0 mg/kg)
ANOVA showed a significant overall effect of reinstatement condition
(F1,6=13.557; p=0.01) but not BRL 44408 dose, and a significant
reinstatement condition × dose interaction (F2,12=4.222; p<0.05).
Similar to yohimbine, BRL 44408 dose-dependently reinstated, with
significant effects observed at the 5 (t6=2.776; p<0.05) and 10
(t7=2.538; p<0.05), but not at the 2.5 mg/kg BRL 44408 doses.

Locomotor Testing
Propranolol, prazosin, and clonidine each produced dosedependent reductions in locomotor activity (Figure 2). One-way
prazosin dose ANOVA examining the effects of 1, 2, and 4 mg/kg
prazosin on locomotor activity showed a significant overall effect
(F1,36=3.300; p<0.05). Post-hoc testing using the Dunnett's t-test
showed that the 4 mg/kg dose, but not the other prazosin doses,
significantly reduced locomotor activity compared with vehicle-treated
controls (p<0.01). Similarly, one-way propranolol dose ANOVA
examining the effects of 5, 10, and 20 mg/kg propranolol on locomotor
activity showed a significant overall effect (F1,36=3.244; p<0.05). PostNeuropsychopharmacology, Vol. 35, No. 11 (October 2010): pg. 2165-78. DOI. This article is © Nature Publishing Group
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hoc testing using the Dunnett's t-test showed that the 20 mg/kg dose,
but not the other propranolol doses, significantly reduced locomotor
activity compared with vehicle-treated controls (p<0.05). One-way
clonidine dose ANOVA examining the effects of 0.03, 0.3, and 1 mg/kg
clonidine on locomotor activity failed to show a significant overall
effect of clonidine, despite a near-significant trend (F3,33=2.693;
p=0.06). Post-hoc testing using the Dunnett's t-test showed that the
1 mg/kg dose, but not the other clonidine doses, significantly reduced
locomotor activity compared with vehicle-treated controls (p<0.05). As
4 mg/kg prazosin, 20 mg/kg propranolol, and 1 mg/kg clonidine
produced significant reductions in locomotor activity, we chose not to
test the effects of these doses on reinstatement.

Figure 2

Effects of clonidine (CLO; a), prazosin (PRZ; b), and propranolol (PRO; c)

or their respective vehicles (Veh) on locomotor activity. To facilitate dose selection,
mice (n=6–10 per dose) were tested for the effects of CLO, PRZ, and PRO on
locomotor activity. Data represent locomotor counts (total photobeam breaks)
measured during a 2-h session that immediately followed drug administration. Each
drug dose-dependently attenuated locomotor activity (*p<0.05; significant reduction
vs Veh).

Reinstatement by Prazosin, Propranolol, Clonidine,
Betaxolol, and ICI-118551
To ensure that the -1 AR antagonist prazosin, the β-AR
antagonists propranolol, betaxolol and ICI-118551, and the -2 AR
agonist clonidine did not, by themselves, alter preference for the
cocaine compartment after extinction, we initially examined the ability
of these drugs, when administered alone, to reinstate extinguished
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conditioned place preference at the doses to be used (Table 1).
Whereas prazosin (1 mg/kg; n=12 or 2 mg/kg; n=14), propranolol
(5 mg/kg; n=8 or 10 mg/kg; n=10), betaxolol (10 mg/kg; n=12), or
ICI-118551 (5 mg/kg; n=12) failed to alter the amount of time spent
in the cocaine-paired compartment after extinction, clonidine, at the
higher (0.3 mg/kg; t12=2.491, p<0.05; n=13) but at not the lower
(0.03 mg/kg; n=13) dose, produced significant reinstatement
(p<0.05).

Effects of Clonidine on Reinstatement
As augmentation of central noradrenergic neurotransmission by
administration of yohimbine or the selective -2A AR antagonist, BRL44408, induced reinstatement, we hypothesized that noradrenergic
neurotransmission during stress or after cocaine exposure may
contribute to stress- and cocaine-induced drug seeking. To test this
hypothesis, mice were tested for FS- or cocaine-induced reinstatement
after administration of clonidine, an -2 AR agonist that suppresses
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evoked increases in NE (Florin et al, 1994; Tjurmina et al, 1999)
presumably by the activation of inhibitory autoreceptors on
noradrenergic nerve terminals.

Forced Swim
The effects of clonidine (0.03 and 0.3 mg/kg, i.p.) on FS-induced
reinstatement are shown in Figure 3. Clonidine suppressed FS-induced
reinstatement, but only at the 0.03 mg/kg dose. A total of 27 mice
were used to test for the effects of 0.03 mg/kg clonidine dose on FSinduced reinstatement (Figure 3a). Two-way repeated-measures FS ×
clonidine treatment condition ANOVA showed a significant overall
effect of FS (F1,26=6.199; p<0.05) but not clonidine treatment
condition on time spent in the cocaine compartment and a significant
clonidine × FS interaction (F1,26=12.264; p<0.01). Post-hoc
examination of reinstatement in each group revealed that FS
significantly reinstated place preference in vehicle-treated but not
clonidine-treated mice (t26=3.230; p<0.05) and that time spent in the
cocaine compartment was significantly reduced by clonidine after FS
(t26=3.012; p<0.05). Nine mice were used to test the effects of the
0.3 mg/kg clonidine dose on FS-induced reinstatement (Figure 3b). In
contrast to the 0.03 mg/kg clonidine dose, 0.3 mg/kg clonidine failed
to block FS-induced reinstatement. Two-way repeated measures FS ×
clonidine treatment condition ANOVA showed a significant overall
effect of FS (F1,8=6.122; p<0.05), but not of clonidine and no FS ×
clonidine interaction.
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Figure 3

The The

-2 AR agonist clonidine dose-dependently blocks stress-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session prior to reinstatement testing (Ext) and
during reinstatement testing after forced swim (FS) after pretreatment with vehicle
(V) or clonidine (Clo). A significant interaction between FS and Clo was found in mice
tested at the 0.03 mg/kg (i.p.) Clo dose (a; n=27; p>0.05). Post-hoc testing showed
that FS increased time spent in the Coc compartment after treatment with V
(#p<0.05) but not 0.03 mg/kg Clo. Further, time spent in the Coc compartment was
significantly reduced after 0.03 mg/kg Clo compared with V (@p<0.05). The effect of
0.3 mg/kg (i.p.) Clo (n=9) on FS-induced reinstatement is shown in b. A significant
main effect of FS (*p<0.05) but no FS × Clo interaction was found at this dose.

Cocaine
The effects of clonidine (0.03 or 0.3 mg/kg, i.p.) on cocaineinduced reinstatement are shown in Figure 4. Neither clonidine dose
blocked cocaine-induced reinstatement. The effect of 0.03 mg/kg
clonidine was tested in 25 mice (Figure 4a). Two-way cocaine ×
0.03 mg/kg clonidine treatment condition ANOVA showed a significant
overall effect of cocaine priming (F1,24=22.807; p<0.001) on time
spent in the cocaine compartment. However, no significant main effect
of clonidine treatment condition or interaction between clonidine
treatment and cocaine-induced reinstatement was found. In all, 13
mice were tested for the effect of a 10-fold higher clonidine dose
(0.3 mg/kg, i.p.) on cocaine-induced reinstatement (Figure 4b). Not
only did this higher clonidine dose fail to block cocaine-induced
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reinstatement, but it also tended to augment reinstatement in
response to cocaine. Similar to the lower clonidine dose, two-way
cocaine × clonidine treatment condition ANOVA showed a significant
overall effect of cocaine priming (F1,12=9.319; p=0.01) on time spent
in the cocaine compartment, with no main effect of clonidine treatment
condition and no interaction between clonidine treatment and cocaineinduced reinstatement.

Figure 4

The

-2 AR agonist clonidine does not block cocaine-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session before reinstatement testing (Ext) and
during reinstatement testing after administration of cocaine (C; 15 mg/kg, i.p.) after
pretreatment with vehicle (V) or 0.03 mg/kg clonidine (i.p.) (Clo; n=25; a) or with V
or 0.3 mg/kg Clo (n=13; b). In both cases, significant main effects of C (*p<0.05) but
no significant C × Clo interactions were found.

Yohimbine
The effects of clonidine on yohimbine-induced reinstatement are
shown in Figure 5. As yohimbine likely reinstates extinguished cocaine
seeking by blockade of -2 ARs, we anticipated that yohimbineinduced reinstatement would be attenuated by clonidine. Surprisingly,
neither the low (ie, 0.03 mg/kg) nor the high (ie, 0.3 mg/kg) clonidine
dose blocked yohimbine-induced reinstatement. A total of 40 mice
were tested for the effects of 0.03 mg/kg clonidine on yohimbineinduced reinstatement (Figure 5a). Two-way repeated-measures
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ANOVA showed a significant overall effect of yohimbine on time spent
in the cocaine compartment (F1,39=13.306) but failed to show a
significant main effect of 0.03 mg/kg clonidine treatment condition or a
significant interaction between clonidine treatment and yohimbineinduced reinstatement. We reasoned that our inability to fully block
yohimbine-induced reinstatement with 0.03 mg/kg clonidine may have
been dose-related because of the competition for the same receptor
site. However, when we tested mice with 0.3 mg/kg clonidine (n=38),
there was little evidence for a reduction of yohimbine-induced
reinstatement at this dose (Figure 5b). Two-way repeated-measures
yohimbine-induced reinstatement × 0.3 mg/kg clonidine treatment
condition ANOVA showed a significant overall effect of yohimbine
(F1,37=8.507; p<0.01), but no overall effect of clonidine pretreatment
and no yohimbine reinstatement × clonidine pretreatment interaction.

Figure 5

The

-2 AR agonist clonidine does not block yohimbine-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session prior to reinstatement testing (Ext) and
during reinstatement testing after administration of yohimbine (Y; 2 mg/kg, i.p.) after
pretreatment with vehicle (V) or 0.03 mg/kg clonidine (i.p.) (Clo; n=40; a) or with V
or 0.3 mg/kg Clo (n=38; b). In both cases, significant main effects of Y (*p<0.05) but
no significant Y × Clo interactions were found.
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Effects of Prazosin on Reinstatement
To examine the role of -1 ARs in reinstatement by various
stimuli, mice were pretreated with the -1 AR antagonist prazosin (2
and 4 mg/kg) before FS or administration of cocaine or yohimbine. In
all cases, prazosin failed to alter reinstatement.

Forced Swim
The effects of prazosin (1 or 2 mg/kg, i.p.) on FS-induced
reinstatement are shown in Figure 6. Neither prazosin dose blocked
reinstatement after FS. The effect of 1 mg/kg prazosin was tested in
five mice (Figure 6a). Two-way repeated-measures FS × 1 mg/kg
prazosin treatment condition ANOVA showed a significant overall effect
of FS (F1,4=12.251; p<0.05) on time spent in the cocaine
compartment. However, no significant main effect of prazosin
treatment condition or interaction between prazosin and FS-induced
reinstatement was found. In all 14 mice were tested for the effect of
2 mg/kg prazosin on FS-induced reinstatement (Figure 6b). Similar to
the lower prazosin dose, two-way repeated-measures FS × 2 mg/kg
prazosin treatment condition ANOVA showed a significant overall effect
of FS (F1,13=5.368; p<0.05) on time spent in the cocaine
compartment, with no main effect of prazosin treatment condition and
no interaction between prazosin and FS.
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Figure 6

The selective

-1 AR antagonist prazosin does not block stress-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session prior to reinstatement testing (Ext) and
during reinstatement testing after forced swim (FS) after pretreatment with vehicle
(V) or 1 mg/kg (i.p.) prazosin (Prz; n=5; a) or pretreatment with V or 2 mg/kg (i.p.)
Prz (n=14; b). In both cases, significant main effects of FS (*p<0.05) but no FS × Prz
interactions were found.

Cocaine
The effects of prazosin on cocaine-induced reinstatement are
shown in Figure 7. Neither prazosin dose blocked cocaine-induced
reinstatement. The effect of 1 mg/kg prazosin was tested in a total of
11 mice (Figure 7a). Two-way cocaine × 1 mg/kg prazosin treatment
condition ANOVA showed a significant overall effect of cocaine
(F1,10=9.000; p<0.05) on time spent in the cocaine compartment.
However, no significant main effect of prazosin treatment condition or
interaction between prazosin and cocaine-induced reinstatement was
found. A total of 13 mice were tested for the effect of 2 mg/kg prazosin
on cocaine-induced reinstatement (Figure 7b). Similar to the lower
prazosin dose, two-way cocaine × 2 mg/kg prazosin treatment
condition ANOVA showed a significant overall effect of cocaine
(F1,12=17.241; p<0.01) on time spent in the cocaine compartment,
with no main effect of prazosin treatment condition and no interaction
between prazosin treatment and cocaine-induced reinstatement.
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Figure 7

The selective

-1 AR antagonist prazosin does not block cocaine-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session before reinstatement testing (Ext) and
during reinstatement testing after administration of cocaine (C; 15 mg/kg, i.p.) after
pretreatment with vehicle (V) or 1 mg/kg (i.p.) prazosin (Prz; n=11; a) or
pretreatment with V or 2 mg/kg (i.p.) Prz (n=13; b). In both cases, significant main
effects of C (*p<0.05) but no C × Prz interactions were found.

Yohimbine
The effects of prazosin on cocaine-induced reinstatement are
shown in Figure 8. Neither prazosin dose blocked yohimbine-induced
reinstatement. The effect of 1 mg/kg prazosin was tested in six mice
(Figure 8a). Two-way repeated measures yohimbine × 1 mg/kg
prazosin treatment condition ANOVA showed a significant overall effect
of yohimbine (F1,5=13.114; p<0.05) on time spent in the cocaine
compartment. However, no significant main effect of prazosin
treatment condition or interaction between prazosin and yohimbineinduced reinstatement was found. In all 15 mice were tested for the
effect of 2 mg/kg prazosin on yohimbine-induced reinstatement (Figure
8b). Similar to the lower prazosin dose, two-way repeated-measures
yohimbine × 2 mg/kg prazosin treatment condition ANOVA showed a
significant overall effect of yohimbine (F1,14=11.558; p<0.01) on time
spent in the cocaine compartment, with no main effect of prazosin
treatment condition and no interaction between prazosin and
yohimbine.
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Figure 8
The selective -1 AR antagonist prazosin does not block yohimbine-induced
reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session prior to reinstatement testing (Ext) and
during reinstatement testing after administration of yohimbine (Y; 2 mg/kg, i.p.) after
pretreatment with vehicle (V) or 1 mg/kg (i.p.) prazosin (Prz; n=6; a) or pretreatment
with V or 2 mg/kg (i.p.) Prz (n=15; b). In both cases, significant main effects of Y
(*p<0.05) but no Y × Prz interactions were found.

Effects of Propranolol on Reinstatement
To examine the role of β-ARs in reinstatement by various
stimuli, mice were pretreated with the nonselective β-AR antagonist,
propranolol, before FS or administration of cocaine or yohimbine.
Propranolol blocked reinstatement by FS and yohimbine, but not
cocaine. Further, FS-induced reinstatement was more sensitive to
blockade by propranolol than yohimbine-induced reinstatement.

Forced Swim
The effects of propranolol (5 or 10 mg/kg, i.p.) on FS-induced
reinstatement are shown in Figure 9. Both propranolol doses blocked
FS-induced reinstatement. The effect of 5 mg/kg propranolol was
tested in seven mice (Figure 9b). Two-way repeated-measures FS ×
5 mg/kg propranolol treatment condition ANOVA failed to show a
significant overall effect of propranolol or FS on time spent in the
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cocaine compartment. However, a significant propranolol × FS
interaction was observed (F1,6=8.598; p<0.05). Post-hoc examination
of reinstatement in each group revealed that FS significantly reinstated
place preference in vehicle- but not 5 mg/kg propranolol-treated mice
(t6=4.32; p<0.05). In all 16 mice were tested for the effects of
10 mg/kg propranolol on FS-induced reinstatement (Figure 9b). Twoway repeated-measures FS × 10 mg/kg propranolol treatment ANOVA
showed a significant main effect of propranolol (F1,15=7.018; p<0.05)
but not FS and a significant interaction between 10 mg/kg propranolol
treatment and FS (F1,15=5.116; p<0.05). Post-hoc examination of
reinstatement in each group revealed that FS significantly reinstated
place preference in vehicle-treated but not 10 mg/kg propranololtreated mice (t15=2.729; p<0.05) and that time spent in the cocaine
compartment was significantly reduced by propranolol after FS
(t15=2.411; p<0.05) but not under basal conditions.

Figure 9

The nonselective β-AR antagonist propranolol blocks stress-induced

reinstatement. Data represent the time spent in the cocaine (Coc) compartment
(sec±SE) during the final extinction session previous reinstatement testing (Ext) and
during reinstatement testing after forced swim (FS) after pretreatment with vehicle
(V) or propranolol (Pro). Significant interactions between FS and Pro were found in
mice tested at the 5 mg/kg (i.p.; a; n=7) and 10 mg/kg (i.p.; b; n=16) Pro doses
(p<0.05). In each case, post-hoc testing showed that FS increased time spent in the
Coc compartment after treatment with V (#p<0.05) but not Pro. Further, time spent in
the Coc compartment was significantly reduced following Pro compared to V at the
10 mg/kg, but not 5 mg/kg, Pro dose (@p<0.05).
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Cocaine
The effects of propranolol (5 or 10 mg/kg, i.p.) on cocaineinduced reinstatement are shown in Figure 10. Neither propranolol
dose blocked cocaine-induced reinstatement. The effect of 5 mg/kg
propranolol was tested in nine mice (Figure 10a). Two-way cocaine ×
5 mg/kg propranolol treatment condition ANOVA showed a significant
overall effect of cocaine (F1,8=9.731; p<0.05) on time spent in the
cocaine compartment. However, no significant main effect of
propranolol treatment condition or interaction between propranolol and
cocaine-induced reinstatement was found. In all 11 mice were tested
for the effect of 10 mg/kg propranolol on cocaine-induced
reinstatement (Figure 10b). Similar to the lower propranolol dose,
two-way cocaine × 10 mg/kg propranolol treatment condition ANOVA
showed a significant overall effect of cocaine (F1,10=13.624; p<0.01)
on time spent in the cocaine compartment, with no main effect of
propranolol treatment condition and no interaction between
propranolol treatment and cocaine-induced reinstatement.

Figure 10

The non-selective β-AR antagonist propranolol does not block cocaine-

induced reinstatement. Data represent the time spent in the cocaine (Coc)
compartment (sec±SE) during the final extinction session before the reinstatement
testing (Ext) and during reinstatement testing after administration of cocaine (C;
15 mg/kg, i.p.) following pretreatment with vehicle (V) or 5 mg/kg (i.p.) propranolol
(Pro; n=9; a) or pretreatment with V or 10 mg/kg (i.p.) Pro (n=11; b). In both cases
significant main effects of C (*p<0.05) but no C × Pro interactions were found.
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Yohimbine
The effects of propranolol (5 or 10 mg/kg, i.p.) on yohimbineinduced reinstatement are shown in Figure 11. Propranolol blocked
yohimbine-induced reinstatement at the 10 mg/kg, but not at the
5 mg/kg dose. The effect of 5 mg/kg propranolol was tested in eight
mice (Figure 11a). Two-way repeated-measures yohimbine × 5 mg/kg
propranolol treatment condition ANOVA showed a significant overall
effect of yohimbine (F1,7=7.865; p<0.05) on time spent in the cocaine
compartment. However, no significant main effect of 5 mg/kg
propranolol treatment condition or interaction between 5 mg/kg
propranolol and yohimbine-induced reinstatement was found. The
effect of 10 mg/kg propranolol on yohimbine-induced reinstatement
was tested in 10 mice (Figure 11b). In contrast to the lower
propranolol dose, 10 mg/kg propranolol prevented reinstatement after
yohimbine administration. Two-way repeated-measures yohimbine
reinstatement × 10 mg/kg propranolol treatment condition ANOVA
failed to show significant main effects of yohimbine or propranolol
(p=0.06) However, a significant interaction between 10 mg/kg
propranolol treatment × yohimbine-induced reinstatement was found
(F1,9=10.563; p=0.01). Post-hoc analyses showed that yohimbine
significantly increased the time spent in the cocaine compartment in
vehicle-pretreated (paired t-test; two-tailed t9=2.334; p<0.05) but not
propranolol-pretreated mice, and that time spent in the cocaine
compartment after yohimbine was significantly reduced in propranololpretreated mice compared with vehicle controls (t9=2.728; p<0.05).
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Figure 11

The nonselective β-AR antagonist propranolol dose-dependently blocks

yohimbine-induced reinstatement. Data in (a) represent the time spent in the cocaine
(Coc) compartment (sec±SE) during the final extinction session before the
reinstatement testing (Ext) and during reinstatement testing after administration of
yohimbine (Y; 2 mg/kg, i.p.) after pretreatment with vehicle (V) or 5 mg/kg (i.p.)
propranolol (Pro; n=8). A significant main effect of Y (*p<0.05) but no Y × Pro
interaction was found at this dose. The effect of 10 mg/kg (i.p.) Pro (n=10) on Yinduced reinstatement is shown in (b). A significant interaction between Y and Pro was
found at this dose (p<0.05). Post-hoc testing showed that Y increased time spent in
the Coc compartment after treatment with V (#p<0.05) but not ICI. Further, time
spent in the Coc compartment was significantly reduced following 10 mg/kg Pro
compared to V (@p<0.05).

Effects of Betaxolol and ICI 118,551 on FS-Induced
Reinstatement
As FS-induced reinstatement seemed to involve β-AR but not 1 ARs, mice were tested with the β-1 AR selective receptor antagonist,
betaxolol (10 mg/kg, i.p.), or the β-2 AR selective antagonist, ICI118551 (5 mg/kg, i.p.), in order to determine the role of β receptor
subtypes in reinstatement by FS (Figure 12). ICI-118551 (Figure 12b)
but not betaxolol (Figure 12a) blocked FS-induced reinstatement. The
effect of betaxolol was tested in 11 mice. Two-way repeated-measures
ANOVA showed a significant main effect of FS on time spent in the
cocaine compartment (F1,10=9.762; p<0.05) but no effect of betaxolol
or FS × betaxolol reinstatement. In all, 11 mice were tested for the
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effect of ICI-118551 on FS-induced reinstatement. Two-way repeatedmeasures ANOVA showed no main effects of ICI-118551 or FS on time
spent in the cocaine compartment. However, a significant ICI-118551
× FS interaction was observed (F1,10=9.364; p<0.05). Post-hoc
analysis showed that FS produced significant reinstatement in vehicle,
but not ICI-118551, treated mice (t10=2.874; p<0.05).

Figure 12

The β-2 AR selective antagonist ICI-118551 but not the β-1 AR

selective antagonist betaxolol blocks stress-induced reinstatement. Data in (a)
represent the time spent in the cocaine (Coc) compartment (sec±SE) during the final
extinction session prior to reinstatement testing (Ext) and during reinstatement testing
after forced swim (FS) following pretreatment with vehicle (V) or betaxolol (Bet;
10 mg/kg, i.p.; n=11). A significant main effect of FS (*p<0.05) but no FS × Bet
interaction was found. The effect of ICI-118551 (ICI; 1 mg/kg, i.p.; n=11) on FSinduced reinstatement is shown in (b). A significant interaction between FS and ICI
was found (p<0.05). Post-hoc testing showed that FS increased time spent in the
cocaine compartment after treatment with V (#p<0.05) but not ICI.

Discussion
Drug re-exposure and stress are commonly cited as
precipitating factors for relapse in recovering cocaine addicts. Although
both stimuli can trigger drug use, they do not necessarily do so
through activation of completely overlapping neurobiological pathways.
The present study poses the noradrenergic system as a likely mediator
of relapse in response to stressors but not cocaine. First, activation of
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central noradrenergic systems through disinhibition of noradrenergic
signaling by administration of the -2 AR antagonist yohimbine or the
more selective -2A AR antagonist BRL 44408 (Dwyer et al, 2010) is
sufficient to induce reinstatement. Second, suppression of
noradrenergic neurotransmission by the administration of the -2 AR
agonist clonidine suppresses reinstatement by FS but not cocaine.
Third, reinstatement by FS and yohimbine, but not cocaine, is blocked
by the nonselective β-AR antagonist propranolol but not by the -1 AR
antagonist, prazosin. In the case of FS, reinstatement is prevented by
the selective β-2 AR antagonist ICI-118551, but not the selective β-1
AR antagonist, betaxolol. Altogether, these findings suggest that
elevated norepinephrine (NE) during periods of stress, but not after
cocaine re-exposure, likely induces drug seeking through activation of
β-2 ARs as measured in this mouse model of relapse.
The apparent role for NE in stressor-induced relapse is also
supported by previous studies. Icv NE administration reinstates
cocaine seeking after SA (Brown et al, 2009), as does disinhibition of
noradrenergic signaling through -2 adrenergic autoreceptor blockade
(Lee et al, 2004; Feltenstein and See, 2006; Fletcher et al, 2008;
Brown et al, 2009) and, in some cases, blockade of NE reuptake (Platt
et al, 2007, but see Schmidt and Pierce, 2006). Conversely,
suppression of stressor-induced NE release through administration of
-2 AR agonists such as clonidine (Tjurmina et al, 1999) attenuates
stress-induced drug seeking after SA of cocaine (Erb et al, 2000),
heroin (Shaham et al, 2000a, 2000b), alcohol (Le et al, 2005; Dzung
Lê et al, 2009), or a heroin–cocaine mixture (Highfield et al, 2001) in
rats, stress-induced reinstatement of morphine-induced place
preference in rats (Wang et al, 2001) and drug craving induced by
stress imagery in heroin-dependent human subjects (Sinha et al,
2007).
Although stress-induced reinstatement was blocked using
propranolol and clonidine, these pretreatments failed to alter
reinstatement in response to cocaine, even though clonidine has been
shown to prevent cocaine-induced increases in brain extracellular NE
levels (Florin et al, 1994). Considering that cocaine, like other NET
blockers that have been shown to induce reinstatement (Platt et al,
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2007), markedly elevates central NE levels (Reith et al, 1997; Li et al,
1996), and that elevation of central NE is sufficient to induce
reinstatement (Brown et al, 2009), our findings suggest that cocaineresponsive processes activated either concurrently with or downstream
from noradrenergic systems are sufficient for relapse in the absence of
a NE response. This assertion is consistent with a number of reports
suggesting that many neurobiological systems underlying stressinduced cocaine seeking (eg, CRF and κ-opioid) do not completely
overlap with those underlying reinstatement in response to cocaine
delivery (Erb et al, 1998; Shaham et al, 1998; Redila and Chavkin,
2008) and is supported by studies showing that suppression of
noradrenergic neurotransmission through -2 AR activation (Erb et al,
2000) or antagonism of central β-ARs (Leri et al, 2002) blocks stressbut not cocaine-induced reinstatement in rats, as well as by findings
that mixed - and β-adrenergic receptor antagonist drugs do not
attenuate the subjective responses to smoked cocaine, despite
reducing peripheral adrenergic responses (Sofuoglu et al,
2000a, 2000b). However, it should be noted that other studies have
indicated that noradrenergic neurotransmission may be involved in
cocaine-induced reinstatement in monkeys (Platt et al, 2007) and rats
(Zhang and Kosten, 2005).
Our finding that propranolol blocks stressor-induced
reinstatement is supported by those of Leri et al (2002), who found
that administration of a combination of β-1 and β-2 AR antagonists
directly into brain regions implicated in stressor-induced cocaine
seeking blocks footshock-induced reinstatement after selfadministration in rats. Propranolol has also been found to block
reinstatement resulting from NET blockade after self-administration in
monkeys (Platt et al, 2007). Further, as β-AR are Gs G-protein coupled
receptors, the findings are consistent with a report that forced swimbut not cocaine-induced reinstatement of conditioned place preference
is dependent on cAMP and CREB activation in mice (Kreibich and
Blendy, 2004). Interestingly, β-blockers have been reported to
attenuate anxiety-like effects resulting from cocaine delivery (Schank
et al, 2008; elevated plus maze) or cocaine withdrawal (Harris and
Aston-Jones, 1993; defensive burying). Thus, to the extent that these
anxiogenic effects contribute to drug craving and relapse during
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withdrawal and/or continued cocaine use, our findings provide further
evidence of potential utility of β-blockers for the management of
cocaine addiction. Despite these findings, clinical trials examining the
ability of propranolol to promote drug abstinence in cocaine-dependent
individuals have found only modest improvement (Kampman et al,
2001, 2006) potentially because of the inability of propranolol to
attenuate cocaine-induced craving and rewarding effects. Consistent
with our own findings, it has been reported that propranolol fails to
decrease cocaine-induced reinstatement in rats (Leri et al, 2002) and
monkeys (Platt et al, 2007) and that drugs with β-AR antagonist
properties fail to alter cocaine's subjective effects (Sofuoglu et al,
2000a, 2000b). In fact, it has been reported that propranolol can
actually augment cocaine's locomotor (Harris et al, 1996 but see
Vanderschuren et al, 2003), discriminative stimulus (Kleven and Koek,
1997; but see Spealman, 1995), and reinforcing effects (Harris et al,
1996). It may be that, because of the selective attenuation of stressinduced cocaine seeking, targeting β-receptors may be more useful as
an adjunct approach and/or only in subpopulations of cocainedependent individuals whose use is stress driven. In support,
Kampman et al (2001, 2006) found that propranolol significantly
increased abstinence time only in cocaine-dependent individuals
experiencing pronounced withdrawal symptoms, which for cocaine
dependence include intense anxiety (Gawin and Kleber, 1986).
In the present study, stressor-induced reinstatement seemed to
involve β-2 AR, presumably within the CNS, but not β-1 AR. FSinduced reinstatement was blocked by the selective β-2 AR antagonist
ICI-118551 but not the β-1 AR antagonist betaxolol. This finding was
somewhat surprising, considering that it has been previously reported
that betaxolol blocked anxiety-like behavior during withdrawal from
chronic cocaine administration (Rudoy and Van Bockstaele, 2007). The
role of β-2 AR in stress- and anxiety-related processes is unclear.
However, β-2 AR are found throughout the rat brain, including in the
BNST (Rainbow et al, 1985) and the amygdala (Tiong and Richardson,
1990), sites in which nonselective antagonism of β-AR has been shown
to attenuate stressor-induced cocaine seeking (Leri et al, 2002) and in
which β-2 AR have been implicated in affective, but not sensory or
somatic, elements of pain (Deyama et al, 2008) or opiate withdrawal
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(Watanabe et al, 2003). Confirmation that central but not peripheral β2 AR activation is required for stress-induced reinstatement will
require further investigation.
In contrast to propranolol, the -1 AR antagonist prazosin (1 or
2 mg/kg) failed to alter reinstatement by any of the stimuli tested. The
finding that prazosin did not alter cocaine-induced reinstatement was
somewhat surprising considering that prazosin has been reported to
attenuate cocaine-induced reinstatement after self-administration in
rats (Zhang and Kosten, 2005) but not monkeys (Platt et al, 2007).
This disparity in prazosin effects on cocaine-evoked reinstatement
across studies could be attributable to a number of factors, including
species, general approach/experimental parameters, and dose. A role
for -1 ARs in a number of cocaine effects has been identified,
including cocaine's reinforcing (Drouin et al, 2002; Wee et al, 2008 but
see Woolverton, 1987), sensitizing (Jiménez-Rivera et al, 2006; Zhang
and Kosten, 2007), locomotor stimulating (Drouin et al, 2002; Snoddy
and Tessel, 1985 but see Vanderschuren et al, 2003), and
discriminative stimulus (Spealman, 1995) effects.
Our finding that yohimbine administration reinstates
extinguished place preference in mice is consistent with previous
reports that yohimbine reinstates extinguished cocaine seeking after
SA in rats (Feltenstein and See, 2006; Fletcher et al, 2008; Brown et
al, 2009) and monkeys (Lee et al, 2004) and impairs the extinction of
cocaine-induce conditioned place preference in mice (Davis et al,
2008). As we were able to block yohimbine-induced reinstatement
with propranolol, we presumed that yohimbine's effects on cocaine
seeking were attributable to disinhibition of noradrenergic activity
resulting from antagonism of -2 adrenergic autoreceptors. Consistent
with this, it has been reported that the highly selective -2 adrenergic
receptor antagonist RS-79948 can induce reinstatement in monkeys
(Lee et al, 2004) and that RS-79948- and yohimbine-induced
reinstatement are blocked by the -2 adrenergic receptor agonist,
clonidine (Lee et al, 2004). A similar clonidine-inhibited β-ARdependent mechanism has been reported to be involved in the
reinstatement of extinguished cocaine seeking by the selective NET
inhibitor, nisoxetine in squirrel monkeys (Platt et al, 2007).
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Surprisingly however, in the present study, clonidine failed to block
yohimbine-induced reinstatement. These findings are consistent with a
recent report that clonidine failed to prevent yohimbine-induced
reinstatement of cocaine seeking after SA in rats (Brown et al, 2009).
It is unclear why clonidine is ineffective in blocking yohimbineinduced reinstatement of cocaine seeking. However, there are two
possibilities. First, yohimbine could be inducing reinstatement through
a non--2 AR mechanism. In support, Davis et al (2008) reported that
the impairment of extinction of cocaine-induced conditioned place
preference and suppression of glutamate-induced electrophysiological
responses in brain slices containing the bed nucleus of the stria
terminalis by yohimbine were unaltered in -2A adrenergic receptor
deficient mice and were not mimicked by the more selective -2A AR
antagonist, atipamezole. Yohimbine has been reported to function as
an agonist at 5-HT1A receptors (Winter and Rabin, 1992; Millan et al,
2000). This 5-HT1A receptor agonist effect may be relevant to drug
seeking, as yohimbine-induced reinstatement of extinguished alcohol
seeking in rats is attenuated by the 5-HT1A receptor antagonist, WAY
100635, as well as clonidine, but is minimally reduced by lesions of
ascending noradrenergic systems (Dzung Lê et al, 2009). To further
examine the role for -2 AR antagonism in reinstatement, we also
tested mice with the selective -2A antagonist BRL 44408, a
compound that has a 50-fold higher affinity for -2A AR relative to 5HT-1A receptors (Dwyer et al, 2010). Like yohimbine, this more
selective -2A AR antagonist also produced robust reinstatement,
suggesting that -2 AR antagonism alone is likely sufficient for
reinstatement. Notably, if indeed yohimbine is working through a
mechanism that is independent of -2 AR, our data suggest that this
mechanism still involves β-AR.
Secondly, clonidine itself is somewhat nonselective. Lower
clonidine doses likely primarily target presynaptic -2 ARs, thereby
competitively reversing yohimbine effects and generally suppressing
noradrenergic neurotransmission through -2 AR-mediated autoinhibitory actions. Accordingly, at the lower (ie, 0.03 mg/kg) dose,
clonidine prevented reinstatement by FS. In addition to attenuating NE
release, higher clonidine doses also activate lower affinity postsynaptic
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-2 ARs and/or bind to imidazoline I1 receptor sites (Bricca et al,
1989; Eglen et al, 1998), thus mimicking components of the
noradrenergic response despite indirectly reducing activation of -1
and β-AR or producing nonnoradrenergic effects. On the basis of our
finding that the higher (ie, 0.3 mg/kg) clonidine dose not only failed to
attenuate yohimbine and FS-induced reinstatement but induced
reinstatement on its own, we hypothesize that, similar to β-AR, these
high-dose targets may contribute to reinstatement during stress. This
finding is consistent with another report that high doses of clonidine
can induce conditioned place preference in rats (Cervo et al, 1993).
Future studies using putative imidazoline receptor ligands as well as
other -2 AR agonists with relatively low affinity for imidazoline
receptors (eg, guanabenz) are needed to determine the relative
contribution of these receptor populations to reinstatement. Overall,
this dose-dependent regulation of differential receptor populations with
varying effects on drug seeking, along with the tendency of yohimbine
to interact with multiple receptor targets, likely contributed to the
observed variation in clonidine's ability to block yohimbine-induced
reinstatement in this study and others.
NE-dependent stress-induced reinstatement seems to involve
projections from the lateral tegmental region of the brainstem to the
bed nucleus of the stria terminalis (BNST) and/or the central nucleus
of the amygdala (CeA) by the ventral noradrenergic bundle and
activation β-ARs. In rats, stress- but not drug-induced reinstatement is
attenuated by administration of clonidine into the lateral tegmentum,
but not the LC (Shaham et al, 2000a, 2000b; heroin) or into the BNST
(Wang et al, 2001; cocaine) or by delivery of a combination of β-1 and
β-2 adrenergic receptor antagonists into the BNST or CeA (Leri et al,
2002; cocaine). It has been postulated that NE released into these
regions regulates the release of corticotropin releasing factor (CRF)
which in turn can indirectly (by actions in the BNST; Erb et al, 2001)
or directly (by actions in the ventral tegmental area; Wang et al,
2005) activate mesocorticolimbic activity, thus producing drug-seeking
behavior. The apparent lack of involvement of CRF (Shaham et al,
1998; Erb et al, 1998) and NE (Erb et al, 2000, Leri et al, 2002, and
present findings; but see Platt et al, 2007, Zhang and Kosten, 2005) in
cocaine-induced reinstatement suggests that despite convergence
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within the mesocorticolimbic system, the neurobiological pathways
underlying drug and stress induced relapse are largely distinct.
β-AR, specifically β-2 AR, have also been implicated in the postretrieval reconsolidation of cocaine-induced conditioned place
preference in mice. Systemic propranolol (Bernardi et al, 2006; FricksGleason and Marshall, 2008) and intrabasolateral amygdalar ICI118551 (Bernardi et al, 2009) injections interfere specifically with the
reconsolidation of conditioned place preference after retrieval without
enhancing extinction learning. As, in our study, mice did not receive
propranolol or ICI-118551 until after place preference had already
been extinguished and as drug administration occurred immediately
before to exposure of the reinstating stimuli, it is unlikely that effects
on reconsolidation contributed to the observed attenuation of
reinstatement. Nonetheless, the potential ability of β-2 AR antagonists
to attenuate stress-evoked relapse and interfere with reconsolidation
of drug-associated memories, establishes β-2 ARs as a target of
interest for the treatment of addiction.
In summary, these findings further suggest that central
noradrenergic systems contribute to drug-seeking behavior during
times of stress. Considering that repeated cocaine exposure is
associated with progressive changes in brain noradrenergic systems
(Belej et al, 1996; Macey et al, 2003; Baumann et al, 2004; Beveridge
et al, 2005; Horne et al, 2008; Lanteri et al, 2008) and that early
abstinence from cocaine in dependent individuals is associated with an
exaggerated noradrenergic response (McDougle et al, 1994), targeting
noradrenergic neurotransmission, particularly β-2 AR, may be
particularly beneficial for the management of relapse in cocainedependent individuals whose drug use is stress-related.
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